Background: Isolated systolic hypertension is an important risk factor for cardiovascular events. The purpose of this study was to detect the prevalence of and to evaluate the effectiveness of currently available medications in the treatment of uncontrolled isolated systolic hypertension. Methods: We randomly selected a total of 585 patients with hypertension from our database. The two most recent blood pressure (BP) readings and other data were obtained by chart review. Results: Of 585 patients, 340 (58%) had controlled BP. Of 245 patients with uncontrolled hypertension, 77.1% had uncontrolled isolated systolic hypertension and the remaining 22.9% had uncontrolled diastolic
A pproximately 50 million Americans have hypertension. 1 It is associated with coronary artery disease, stroke, and end-stage renal disease. 2, 3 In addition, it leads to high morbidity and mortality and is associated with increased cost. Despite the provision of guidelines for primary care physicians by the Joint National Committee for detection, evaluation, and treatment of high blood pressure (JNC), 4 hypertension is not well controlled in the United States. According to National Health and Nutritional Examination Survey-III (NHANES-III), only 27% of hypertensive patients had BP controlled to below 140/90 mm Hg.
Isolated systolic hypertension has been shown to be an important risk factor for cardiovascular morbidity and mortality. 5, 6 Increased pulse pressure has recently been shown to be an independent risk factor for increased cardiovascular mortality among patients with isolated systolic hypertension. 7 We have observed that isolated systolic hypertension is more difficult to control. This study is designed to detect the prevalence of uncontrolled isolated systolic hypertension among patients with poor BP control. The secondary aim of this study is to evaluate the effectiveness of currently available medications in controlling isolated systolic hypertension.
Methods

Patients
All patients seen at the Central Arkansas Veterans Healthcare System in Little Rock, Arkansas (CAVHS) during the years 1998 to 1999 were eligible for the study. Patients whose BP readings were not available were excluded from the study. Hypertensive patients were identified by ICD codes. The CAVHS was selected for two major reasons: 1) most of the vital data was computerized and 2) nearly all of these patients have access to healthcare and free medications.
Study Design
This is a cross-sectional study. Hypertension was defined as systolic BP Ͼ139 mm Hg or diastolic BP Ͼ89 mm Hg. Uncontrolled systolic hypertension was defined as a systolic BP Ͼ139 mm Hg and diastolic BP Ͻ90 mm Hg. Diastolic hypertension was defined as diastolic BP Ͼ89 mm Hg regardless of systolic BP. The two most recent BP readings were obtained from the computer and mean systolic and diastolic BP were calculated. Pulse pressure was calculated by subtracting diastolic BP from systolic BP. Mean arterial pressure was calculated by adding one-third of the pulse pressure to the diastolic BP. Medication lists were obtained from the computer. Only current medications were included and analyzed according to their respective classes. Comorbidities were identified by ICD codes.
Statistical Analysis
For sample size calculation, it was assumed that 70% of patients with uncontrolled hypertension will have uncontrolled isolated systolic hypertension and 30% will have uncontrolled diastolic hypertension. To determine a 95% confidence interval (CI) with a desired width of 5% (0.05), 323 subjects with uncontrolled hypertension will be required. As per NHANES-III data, 70% of hypertensive patients have uncontrolled BP. All patients included in this study have access to health care and, therefore, uncontrolled hypertension was expected to be lower than what was reported by NHANES-III. Assuming that 60% of the patients in our study group will have uncontrolled hypertension, a sample size of 539 subjects with hypertension was estimated for the study. However, the sample size was adjusted upward by about 20%, increasing the total number of hypertensive subjects to 650 to compensate for dropouts. In view of the retrospective nature of the study, a larger number of dropouts would be expected due to unavailability of data.
Analysis was performed using SPSS-10 software (SPSS, Inc., Chicago, IL). Patients with missing data were excluded from the analysis. For continuous variables, ANOVA with post-hoc test was used. Where appropriate Student t test was used for continuous variables. For categoric variables, 2 analysis was performed. A P value of Ͻ .05 was considered statistically significant. Multivariable analysis was performed to assess the association of uncontrolled systolic hypertension with age, serum creatinine, diabetes, coronary artery disease, congestive heart failure, cerebrovascular accident, and total number of antihypertensive medications the patients were taking. Ethnicity and sex were not included in the multivariable analysis as the information on ethnicity is not a part of medical records at our institution. Sex was not included in the multivariable analysis because our patients are veterans and the majority of them are men.
Results
A total of 6875 patients with diagnosis of hypertension were identified during the years 1998 and 1999 by ICD codes. To ensure true representation of the CAVHS population, all patients were assigned a number from 1 to 6875. Subsequently, 650 patients were randomly selected using computer-generated random numbers. On 585 patients, sufficient data was available to include in the final analysis. Sixty-five patients were excluded because of deficiency of important data. Considering cross-sectional study design and retrospective chart review, dropout rate was not significant and was unlikely to affect the outcome of the results. We believe that our study patients represent the Veteran Affairs population because of a large sample size and random selection. Table 1 shows the patients characteristics as mean Ϯ SD or as a percentage.
Of 585 patients, 340 (58%) had controlled BP and 245 (41.9%) had uncontrolled hypertension. Of 245 uncontrolled hypertensive patients, 189 (32.3% of total) had uncontrolled isolated systolic hypertension, and 56 (9.6% of total) had uncontrolled diastolic hypertension (Fig. 1A) . Among all patients who had uncontrolled hypertension, 77.1% had isolated systolic hypertension (Fig. 1B) .
The mean age of patients with uncontrolled systolic hypertension was 68.7 years (95% CI, 67.09 -70.35), whereas the mean age of patients with uncontrolled diastolic hypertension was 56.05 years (95% CI 53.04 -59.06; P Ͻ .001). Mean arterial pressure was lower in patients with uncontrolled isolated systolic hypertension (95% CI 101.04 -103.23) as compared to uncontrolled diastolic hypertension (95% CI 113.31-117.52; P Ͻ .001). The pulse pressure was higher in patients with uncontrolled isolated systolic hypertension as compared to patients with controlled BP and patients with uncontrolled diastolic hypertension (P Ͻ .001) (Fig. 2) .
The mean number of medications was 1.89 Ϯ 0.05 (mean Ϯ SE). One-way ANOVA showed that there were significant differences in mean number of medications among different group of patients (P Ͻ .034). A post-hoc test showed that patients with uncontrolled systolic hypertension were on average taking more medications (2.10 Ϯ 0.09) compared to patients with controlled BP (1.78 Ϯ 0.07; P ϭ .025). Likewise, patients with uncontrolled systolic hypertension were receiving more antihypertensive medications compared to patients with uncontrolled diastolic hypertension (1.87 Ϯ 0.18). In multivariable analysis, only age and number of antihypertensive medications were independently associated with uncontrolled systolic hypertension (␤ 0.03 and P ϭ .001 for age and ␤ ϭ 0.19 and P ϭ .04 for number of antihypertensive medications), whereas the association of uncontrolled isolated systolic hypertension with serum creatinine, diabetes, coronary artery disease, congestive heart failure, and cerebrovascular accident were not statistically significant.
Discussion
The Veteran Affairs cooperative study was one of the earliest controlled clinical trials that showed the benefit of treatment of hypertension. 8 In this trial, patients were divided into those with mild-to-moderate hypertension and those with severe hypertension based on the level of diastolic BP. Since then, diastolic BP control was the main focus of therapy.
Several large studies have shown that lowering isolated systolic hypertension was associated with a lower incidence of stroke and other cardiovascular events. On the basis of the NHANES-III data, 9 isolated systolic hypertension accounts for 64.9% of patients with uncontrolled BP. In patients aged Ͼ50 years, 79.8% have uncontrolled isolated systolic hypertension. With increasing age of the US population, physicians are expected to see more patients with isolated systolic hypertension.
Despite data supporting the adverse effects of isolated systolic hypertension, it remains a difficult problem to treat. In our study, 77.1% of patients with uncontrolled hypertension had isolated systolic hypertension. Although our population was different from NHANES-III, which indirectly represents the general population of US, we found the prevalence of uncontrolled hypertension was fairly similar. Most of our patients were known with hypertension, seen by a physician, and were receiving medical treatment. Hayman and Pavlik 10 evaluated NHANES-III data and reported a 76.9% prevalence of uncontrolled isolated systolic hypertension among patients who were receiving treatment for hypertension and had uncontrolled BP, which is in agreement with our study.
There are several barriers to BP control, including socioeconomic status, access to health care, noncompliance with medications, inappropriate therapy, and access to primary care physicians. Hayman and Pavlik 10 examined the NHANES-III data to characterize the patients with uncontrolled hypertension. They concluded that most cases of uncontrolled hypertension consisted of patients with mild isolated systolic hypertension, most of which had access to health care and had primary care physicians. It was suggested that the standards of medical practice might be a factor contributing to uncontrolled hypertension. In our study, most of the patients had access to health care and free medications. On average, patients with uncontrolled systolic hypertension were receiving more medications than those with controlled hypertension. This indicates that physicians were attempting 
FIG. 2.
Box plot illustrating distribution of pulse pressure according to hypertension control. *P Ͻ .001, compared to patients with controlled hypertension; **P Ͻ .001, compared to patients with controlled hypertension. HTN ϭ hypertension; other abbreviations as in Fig. 1. to control BP by prescribing additional medications. Furthermore, most of the patients with uncontrolled systolic BP were receiving diuretics and calcium channel blockers, which are recommended under these circumstances (JNC-VI). This further supports our hypothesis that available antihypertensive medications are not very effective in controlling systolic BP. In the Systolic Hypertension in the Elderly Program (SHEP), 6 a ␤-blocker and diuretic were used, whereas in the Systolic Hypertension in Europe (Syst-Eur) trial, 11 a calcium channel blocker was used as first-line therapy. In our study, 43.1% were on diuretics, 41.9% on angiotensin converting enzyme inhibitors, 35% on ␤-blockers, 32.9% were on calcium channel blockers, and none of the BP medications were significantly associated with better BP control.
Vaccarino et al 12 reevaluated the SHEP trial data and found that in the treatment group, an increase of 10 mm Hg of pulse pressure was associated with a 32% increase in risk of heart failure and 24% increase in risk of stroke after controlling for the systolic BP. Furthermore, recently Somes et al 13 reanalyzed the SHEP trial data and showed that those patients who had a cardiovascular event while on antihypertensive medications had a lower diastolic BP than those who did not have an event. In our study, pulse pressure positively correlated (r ϭ 0.3, P Ͻ .001) with age. Also mean pulse pressure was higher in patients with uncontrolled isolated systolic hypertension as compared to uncontrolled diastolic hypertension (95% CI 76.35-76.54, 55.3-58.7, respectively).
Isolated systolic hypertension represents a different pathophysiologic mechanism as compared to diastolic hypertension. High systolic BP and wide pulse pressure reflect atherosclerotic stiffening of the large vessels 14 and, therefore, systolic BP and pulse pressure are better predictors of atherosclerotic cardiovascular and cerebrovascular disease events. As such, one would not expect drugs developed for and found to be effective in treating diastolic hypertension to be similarly effective in a disease process that represents vascular consequences of atherosclerosis and arterial stiffness. There is a need to develop new medications 15 that will control isolated systolic hypertension. Ideally, these medications should effectively lower systolic BP without significantly affecting the diastolic BP and thus decreasing the pulse pressure.
Limitations to this study are that it is an observational study and no causality can be concluded. We had no control on treatment or dosage of medications. It was not possible to monitor the compliance. The Veterans Administration patients were men and the average age was 65 Ϯ 12.6 years. Our results showed an overall better BP control than NHANES-III because all our patients were known hypertensive and had access to health care, which was not the case for NHANES-III's patient population. Despite these limitations, our study reconfirms that hypertension is not well controlled, even among patients with access to health care. The major contributor to uncontrolled hypertension is poorly controlled isolated systolic hypertension. We believe that the major reason for poor control of isolated systolic hypertension is the unavailability of medications that can effectively control it without decreasing the diastolic BP. There is a need for more effective medications to control systolic hypertension. Further studies are needed to identify new approaches in controlling isolated systolic hypertension and pulse pressure without significantly lowering diastolic BP.
